• 1. Synthesis of quinolines via copper-catalyzed domino reactions of enaminones
  Benyapa Kaewmee,Vatcharin Rukachaisirikul,Juthanat Kaeobamrung Org. Biomol. Chem. 2017 15 7387
• 2. The synthesis of novel heterocyclic substituted α-amino acids; further exploitation of α-amino acid alkynyl ketones as reactive substrates
  Robert M. Adlington,Jack E. Baldwin,David Catterick,Gareth J. Pritchard,Lam T. Tang J. Chem. Soc. Perkin Trans. 1 2000 2311
• 3. Factors influencing the chelate linkage isomerism of some oxime complexes of nickel(II)
  Micheal J. Lacey,James S. Shannon,Colin G. Macdonald J. Chem. Soc. Dalton Trans. 1974 1215
• 4. Synthesis of unsymmetrical NH-pyrroles from biomass feedstock in the confined space of metal–organic frameworks
  Deng-Yue Zheng,Tianjian Zhang,Rongxian Bai,Minghao Li,Ruifeng Wang,Yanlong Gu Green Chem. 2023 25 915
• 5. Syntheses of quinazolinones from 2-iodobenzamides and enaminones via copper-catalyzed domino reactions
  Teerawat Songsichan,Jaturong Promsuk,Vatcharin Rukachaisirikul,Juthanat Kaeobamrung Org. Biomol. Chem. 2014 12 4571

• Solvents and Organic Chemicals Organic Compounds Amines/Sulfonamides

Recent Advances in the Study of 4-Aminopent-3-en-2-one (CAS: 1118-66-7): A Comprehensive Research Brief

4-Aminopent-3-en-2-one (CAS: 1118-66-7) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. This β-aminoketone derivative has garnered attention due to its versatile reactivity and potential applications in drug discovery, particularly as a building block for the synthesis of bioactive molecules. Recent studies have explored its role in the development of novel therapeutic agents, with a focus on its unique structural and electronic properties that enable diverse chemical transformations.

One of the key areas of research involving 4-Aminopent-3-en-2-one is its utility in the synthesis of heterocyclic compounds, which are prevalent in many FDA-approved drugs. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its effectiveness as a precursor for the construction of pyrrole and pyridine derivatives, which exhibit promising antimicrobial and anticancer activities. The study highlighted the compound's ability to undergo regioselective reactions, enabling the efficient synthesis of complex molecular architectures.

In addition to its synthetic applications, 4-Aminopent-3-en-2-one has been investigated for its potential as a ligand in metal-catalyzed reactions. A recent preprint on ChemRxiv (2024) reported its use in palladium-catalyzed cross-coupling reactions, where it facilitated the formation of carbon-carbon bonds under mild conditions. This advancement is particularly relevant for the pharmaceutical industry, where such reactions are critical for the scalable production of drug candidates.

Another notable development is the exploration of 4-Aminopent-3-en-2-one in the context of prodrug design. Researchers at the University of Cambridge (2023) utilized its ketone functionality to develop pH-sensitive prodrugs that release active therapeutic agents in targeted physiological environments. This approach holds promise for improving the bioavailability and reducing the side effects of existing drugs, particularly in oncology.

Despite these advancements, challenges remain in the large-scale production and purification of 4-Aminopent-3-en-2-one. A 2024 review in Organic Process Research & Development discussed the need for more sustainable and cost-effective synthetic routes, emphasizing the importance of green chemistry principles. Future research directions may focus on biocatalytic methods or flow chemistry to address these limitations.

In conclusion, 4-Aminopent-3-en-2-one (CAS: 1118-66-7) continues to be a valuable scaffold in chemical biology and pharmaceutical research. Its multifaceted reactivity and potential therapeutic applications make it a compound of enduring interest. Ongoing studies are expected to further elucidate its mechanistic pathways and expand its utility in drug discovery and development.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)